|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 15190 |
FusionGeneSummary for GPCPD1_ZNF91 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: GPCPD1_ZNF91 | Fusion gene ID: 15190 | Hgene | Tgene | Gene symbol | GPCPD1 | ZNF91 | Gene ID | 56261 | 7644 |
| Gene name | glycerophosphocholine phosphodiesterase 1 | zinc finger protein 91 | |
| Synonyms | EDI3|GDE5|GDPD6|PREI4 | HPF7|HTF10 | |
| Cytomap | 20p12.3 | 19p12 | |
| Type of gene | protein-coding | protein-coding | |
| Description | glycerophosphocholine phosphodiesterase GPCPD1endometrial differential 3glycerophosphocholine phosphodiesterase GDE1 homologglycerophosphodiester phosphodiesterase 5preimplantation protein 4putative glycerophosphocholine phosphodiesterase GPCPD1puta | zinc finger protein 91zinc finger protein 91 (HPF7, HTF10)zinc finger protein HPF7zinc finger protein HTF10 | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | Q9NPB8 | Q05481 | |
| Ensembl transtripts involved in fusion gene | ENST00000481038, ENST00000379019, | ENST00000596528, ENST00000599743, ENST00000300619, ENST00000397082, | |
| Fusion gene scores | * DoF score | 2 X 2 X 1=4 | 1 X 1 X 1=1 |
| # samples | 2 | 1 | |
| ** MAII score | log2(2/4*10)=2.32192809488736 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: GPCPD1 [Title/Abstract] AND ZNF91 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | ZNF91 | GO:0045892 | negative regulation of transcription, DNA-templated | 25274305 |
| Tgene | ZNF91 | GO:0070895 | negative regulation of transposon integration | 25274305 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AW377070 | GPCPD1 | chr20 | 5567951 | + | ZNF91 | chr19 | 23541550 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-5UTR | ENST00000481038 | ENST00000596528 | GPCPD1 | chr20 | 5567951 | + | ZNF91 | chr19 | 23541550 | + |
| intron-intron | ENST00000481038 | ENST00000599743 | GPCPD1 | chr20 | 5567951 | + | ZNF91 | chr19 | 23541550 | + |
| intron-3UTR | ENST00000481038 | ENST00000300619 | GPCPD1 | chr20 | 5567951 | + | ZNF91 | chr19 | 23541550 | + |
| intron-intron | ENST00000481038 | ENST00000397082 | GPCPD1 | chr20 | 5567951 | + | ZNF91 | chr19 | 23541550 | + |
| intron-5UTR | ENST00000379019 | ENST00000596528 | GPCPD1 | chr20 | 5567951 | + | ZNF91 | chr19 | 23541550 | + |
| intron-intron | ENST00000379019 | ENST00000599743 | GPCPD1 | chr20 | 5567951 | + | ZNF91 | chr19 | 23541550 | + |
| intron-3UTR | ENST00000379019 | ENST00000300619 | GPCPD1 | chr20 | 5567951 | + | ZNF91 | chr19 | 23541550 | + |
| intron-intron | ENST00000379019 | ENST00000397082 | GPCPD1 | chr20 | 5567951 | + | ZNF91 | chr19 | 23541550 | + |
Top |
FusionProtFeatures for GPCPD1_ZNF91 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| GPCPD1 | ZNF91 |
| May be involved in the negative regulation of skeletalmuscle differentiation, independently of its glycerophosphocholinephosphodiesterase activity. {ECO:0000250}. | Transcription factor specifically required to repressSINE-VNTR-Alu (SVA) retrotransposons: recognizes and binds SVAsequences and represses their expression by recruiting arepressive complex containing TRIM28/KAP1 (PubMed:25274305). Mayalso bind the promoter of the FCGR2B gene, leading to repress itsexpression; however, additional evidences are required to confirmthis result in vivo (PubMed:11470777).{ECO:0000269|PubMed:25274305, ECO:0000305|PubMed:11470777}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for GPCPD1_ZNF91 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for GPCPD1_ZNF91 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for GPCPD1_ZNF91 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for GPCPD1_ZNF91 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | GPCPD1 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|